chrisvoncsefalvay/vaers-outcomes huggingface dataset:
One day after booster in right arm (on 12/18), he noticed right pinky and ring finger numbness which then extended up to his elbow. The next day after that the same symptoms occurred on his left side. He had about two weeks of intermittent symptoms, and then five days of persistent neuropathy with associated grip weakness. Today when speaking to him (1/7/22) he now has persistent bilateral upper extremity neuropathy from his hands to elbows, with associated weakness (trouble opening up bottles) as well as feeling that his gait is different (more unsteady).
Vaccine that administered beyond use date after the thaw process/expired vaccine administered; This spontaneous case was reported by a paramedic and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process/expired vaccine administered) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 prophylaxis.     It was unknown if patient had acute illness at the time of vaccination and up to one month before. It was unknown if patient had been diagnosed with or tested positive for COVID-19.     On 29-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 29-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process/expired vaccine administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process/expired vaccine administered) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  Vaccine were administered beyond use date after the thaw process to the patients. There was no patient that had any adverse reactions and no reports of any reactions after the administration of the vaccines.  Treatment medications were not reported.
Blood clots during period..quater size; Migraine; Body aches; Profusely sweating; This is a spontaneous report from a non-contactable consumer (patient). A 39-year-old female patient (non-pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on 07Sep2021 (Lot Number: 301308A) at the age of 39-year-old as single dose covid-19 immunization. Medical history included allergies. The patient's concomitant medications were not reported. The patient had not taken other vaccine in four weeks. Patient had no COVID prior vaccination and was not COVID tested post vaccination. The patient experienced blood clots during period-quater size, migraine, body aches and profusely sweating in Sep2021 with outcome of unknown.    No follow-up attempts are possible. No further information is expected.
PATIENT AWOKE HAVING ASTHMA ATTACK. USED ALBUTEROL INHALER AND WITHIN 1 HOUR SYMPTOMS HAD CEASED.
This spontaneous report was received from an office manager and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions and concomitant medications were not reported. On 01-AUG-2017, the patient received an improperly stored dose in immunization series of GARDASIL 9 injection (lot # N013695 with expiration date at 21-MAR-2019; strength, exact dose, route of administration and anatomical location were not reported), for prophylaxis. The administered dose of vaccine was exposed to a temperature of 32 degrees Fahrenheit (F) for 168 hours. There was no previous temperature excursion. Data logger was not used to track the temperature. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several report received form the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1708USA004073: US-009507513-1708USA004071: US-009507513-1708USA003345: US-009507513-1708USA004072.
Don't know when it actually started but.. used my wife's pulse oximeter on Wednesday evening on date previously given (she has Hypoxemia and a number of other health problems and also may have had a more dramatic adverse event after her third shot). I was feeling very slightly short of breath. My oxygen saturation was 75. We monitored it the rest of the evening and I used some of her supplemental oxygen to get it back up. This is Saturday and I have been checking my oxygen saturation periodically since Wednesday. Though I don't feel symptomatic, my O2 levels are routinely 90-93. They have been as low as 75-85. I had no problems with the first two shots except a sore arm and brief flu-like aches. I had that with shot #3 for only about maybe 5 hours. I got all three shots in the left arm. The first two were from my local Health Dept. I have a Primary Care Physician appointment in about 10 days and plan to mention it then unless I have to address it elsewhere first.
tired/Felt tired and weak and he did not receive his second dose; weak/Felt tired and weak and he did not receive his second dose; Really bad back pain like I could not move my back as my back hurt so bad; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A 41 year-old male patient received bnt162b2 (BNT162B2), administered in arm, administration date 30Apr2021 (Lot number: EW0176) at the age of 40 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Hypertension" (unspecified if ongoing); "Hydrocephalus" (unspecified if ongoing). Concomitant medication(s) included: ZOLOFT. The following information was reported: FATIGUE (non-serious) with onset 30Apr2021, outcome "unknown", described as "tired/Felt tired and weak and he did not receive his second dose"; ASTHENIA (non-serious) with onset 30Apr2021, outcome "unknown", described as "weak/Felt tired and weak and he did not receive his second dose"; BACK PAIN (non-serious) with onset 30Apr2021, outcome "unknown", described as "Really bad back pain like I could not move my back as my back hurt so bad". Therapeutic measures were taken as a result of fatigue, asthenia, back pain.  Additional information: It is a consumer who received their first dose (clarified as: Pfizer-BioNTech COVID-19 Vaccine) on 30Apr of this year and afterwards he felt tired and weak and he did not receive his second dose and he still has not received his second dose as of today. So, that would be greater than 42 days if he decides to get the second dose. And he is 41 years old. So, he was calling because he got his first dose on 03Apr and he felt tired and weak. So, he did not get the second dose. So, he wanted to know if he can still have the second dose. It started getting worst that night. started experiencing a little bit of tired that day. And then when it really hit me the most was the next day. I had like really bad back pain like I could not move my back as my back hurt so bad." Treatment received Patient took like Advil and stuff."  No follow-up attempts are possible. No further information is expected.  No follow-up attempts are possible. No further information is expected.
Extreme dizziness that got better a few hours later but reoccurred the next day (29th) and was worse, numbness in arm given for a few hours
Anaphylaxis, started with red rash growing on his face which spread rapidly. His face was hot. Both eyes got puffy but his right eyelid swelled until almost closed, hives on his torso, legs, and arms. His ears and lips began to turn red and grow puffy also. He vomited a few minutes later and began noticeably wheezing. We called the doctor who directed us to administer 3/4 teaspoon of BENADRYL. We gave that to him and took him to ER. Arrived at ER around 2:45pm. At the ER he was observed but he began to recover around 3:00pm. Redness and symptoms persisted for hours but noticeably improved at 3:00pm. They recommended overnight stay but said it was ok to take him home and administer additional BENADRYL every 6 hours for 1 day.
Received flu vaccine on 10/18/13. About 1 hour after the site and surrounding area approx 2" in diameter became red and itchy by 1PM it was size of a tennis ball - hard lump swollen and 2 inches out with pain up the back of neck and to hand.
Redness, swelling and heat at injection site and itchy 70mm x 70 mm - started 6/6/08 after work; started Benadryl 25mg BID. 6/9/08 redness reduced to 20mm x 20mm.
Warm to the touch; Itchiness at the injection site/ more of an itch; Light swelling at the injection site; Rash at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE PRURITUS (Itchiness at the injection site/ more of an itch), VACCINATION SITE SWELLING (Light swelling at the injection site) and VACCINATION SITE RASH (Rash at the injection site) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included LOSARTAN POTASSIUM (LOSARTIN), ROSUVASTATIN and AMLODIPINE for an unknown indication.    On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE PRURITUS (Itchiness at the injection site/ more of an itch), VACCINATION SITE SWELLING (Light swelling at the injection site) and VACCINATION SITE RASH (Rash at the injection site). On 13-Apr-2021, VACCINATION SITE SWELLING (Light swelling at the injection site) had resolved. At the time of the report, VACCINATION SITE WARMTH (Warm to the touch) and VACCINATION SITE PRURITUS (Itchiness at the injection site/ more of an itch) had not resolved and VACCINATION SITE RASH (Rash at the injection site) outcome was unknown.            No treatment information was provided.
EXTREME MUSCLE ACHES AND PAIN IN RIGHT ARM, JOINT PAIN IN HIPS, RESTLESS MUSCLES IN LEGS
We believe a monovalent dose for age 5-11 was given instead of the bivalent booster.
Pt received SHINGRIX vaccine at approx. 1430 30 Jan 2019. Pt reported having a minor headache around 1530 30 Jan 2019. Wife of patient reported patients headache feeling worse and patient 'not feeling right' which prompted him to go to bed earlier than usual. Wife of patient called today 31 Jan 2019 at 1400 saying patient is still in bed complaining of fatigue, fever, and a severe headache.
Information has been received from a lawyer regarding a case in litigation concerning a male patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On an unspecified date the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles.  The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 08-MAR-2016, the patient was treated by a physician for the onset of severe vesicular rash, which was diagnosed as herpes zoster, or shingles. The patient had been prescribed valacyclovir (VALTREX) for management of his symptoms and pain. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. Additional information has been requested.
Presented to HD - while here started to develop "spots" some larger than other with the appearance of typical varicella vaccine type reaction (1) on (R) foot - (2) on leg noted. No fever. Acting normally, playing.
Swelling Left clavicle lymph node golf ball size. Numbness Left jawline, cheek and a little on neck.
developed sore throat, stuffy nose on 6/17/22, tested positive on home covid test
Improperly stored dose of GARDASIL 9 was administered to the patient on an unknown date; No adverse effects; This spontaneous report was received from a medical assistant, referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug allergies/reactions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) lot # N022952, expiration date: 14-JUN-2020 (strength, dose, schedule and route of administration were unknown) for prophylaxis (product storage error). The vaccine underwent temperature excursion below 36-degree Fahrenheit: 32.1 Fahrenheit for a duration of 8 hours. There was no previous temperature excursion. There was an involvement of data logger. No product quality complaints (PQC) were involved.
ache/pain on the left side of her neck (somehow near her left ear, close to the base of her left skull, not in the middle but close to the left side); ear pain; the pain is more bothersome underneath and moved to the base of her skull; she was nervous and does have several allergies; rash on her face; hives; bump in the arm which is sore; bump in the arm which is sore; This is a spontaneous report from a contactable consumer (patient). A 52-year-old female patient received bnt162b2 (COMIRNATY), first single dose via an unspecified route of administration, administered in arm left on 04Oct2021 at 13:00 (Batch/Lot number was not reported) for covid-19 immunisation at age of 52-year-old. Medical history included pre-existing thyroid condition, a little bit overweight, but over-all healthy. The patient's concomitant medications were not reported. Patient reported to have gotten her 1st dose of the COMIRNATY vaccine the day before this report on 04Oct2021. Post-vaccination she developed rash on her face, hives and bump in the arm which was sore. She reported that the rash completely cleared up. However, she observed around 8:30- 9:30 AM the day at this report on 05Oct2021 that she woke up with the ache/pain on the left side of her neck (somehow near her left ear, close to the base of her left skull, not in the middle but close to the left side. She also mentioned that she got the vaccine on her left arm. Patient stated she had the 1st dose of the Pfizer Vaccine and after the shot around 1:00pm she did have a reaction as far as she broke out in a rash on her face with hives and was taking Benadryl; stated she talked to the pharmacist who noticed this an hour after the shot was given and she had waited after her shot because she was nervous and did have several allergies; stated by this morning her face was all cleared up except for one bump which was good and her arm being sore; stated what was bothering her now was that she woke up with some aching up the left side of her neck into her left ear and that is doable and was there so she will see how that pans out. Patient stated the pain went away and then came back and she did not know why this is happening. Patient stated she can ignore the ear thing but what made her nervous was that pain in the base of her skull close to the left side and it is bothersome. Patient stated she did print everything out before she got the shot and did not see anyone reporting anything like neck or ear pain and the neck was what was being annoying now and the ear pain was there. Outcome of the events rash on her face and hives was recovered in Oct2021, while outcome of the other events was unknown. Events rash on her face and hives reported as serious as medically significant.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
pt recvd vax;48 hrs later,was limp,v,rash,fever 105,unresponsive;to er,seen by MD;blood tests;mom said rash started same day as immun;
29JUN93 115PM pt was taken to ER w/fever, bluish skin color, & not acting right; was examined by MD-t105.44; 30JUN93 seen by MD whelpy rash, itchy, afebriel, pharyngitis & ear infect; sx of ATB allergy-purpura rash;
This case was reported by a physician via sales rep and described the occurrence of delirium in a elderly male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced delirium (serious criteria GSK medically significant). On an unknown date, the outcome of the delirium was unknown. It was unknown if the reporter considered the delirium to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The physician reported that delirium in the patient after receiving the SHINGRIX.
Headache, watery eyes, blurry vision, post-nasal drip, runny nose, sore throat, muscle and joint aches, low-grade fever (100),diarrhea. All symptoms occurred within 4 hrs of "Flu-Mist". treated with Motrin 800 mg /6 hrs and Dayquil.
(L) arm pain, swelling, cellulitis, headaches. BACTRIM, KEFLEX 500 mg, ibuprofen 600 mg, triamcinolone acetonide, ROCEPHIN gram, ketorolac tromethamine, IV hydration.
Day 1: sore arm; tired Day 2: lightheaded (nearly fainted)-next morning; fever, shivering; large itchy rash in injection site; tired Day 3: tired; large itchy rash Day 4: tired; large itchy rash
cellulitis;swollen, red, warm-no fever;ATB keflex-PO TID x 10 days;
9 days after vaccination, arm became slightly itchy, red about 2? diameter, knot-like to touch
small nodule on left collar bone; Left arm pain; general fatique; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 09Nov2023 at 14:00 as dose 1, single (Lot number: Unknown) at the age of 47 years, in left arm for covid-19 immunisation; influenza vaccine (INFLUENZA), on 09Nov2023 (Batch/Lot number: unknown), in left arm. The patient had no relevant medical history. Concomitant medication(s) included: ADVIL [IBUPROFEN]. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 09Nov2023 at 18:00, outcome "not recovered", described as "Left arm pain"; FATIGUE (non-serious) with onset 09Nov2023 at 18:00, outcome "not recovered", described as "general fatique"; NODULE (non-serious) with onset 09Nov2023 at 18:00, outcome "not recovered", described as "small nodule on left collar bone". Therapeutic measures were not taken as a result of nodule, vaccination site pain, fatigue.  Additional information: Patient has no allergy history. Patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19 prior to vaccination or since the vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
One week after, I developed a rash from my elbow to my shoulder. It is warm to the touch and a bit swollen and red. A little itchy.
On day 10 post vaccine pt developed mild lymphadenopathy, fever, chills at home. (He took ibuprofen) local inflammation around site of approx 3-4 inches.
Irritated nerves on left chest which started 15 min after the injection and continue on and off until now, two weeks later.  The severity and frequency decrease over time.  To a lesser degree, also experience irritated stomach nerves.  Frequently out of breath and very tired.
Sore arm injected shot top left arm broke out hives later middle top of same arm.
Within 24 hours of receiving vaccine during the evening of 10/05/04. Child was irritable, wetting pants (was potty trained) began throwing temper tantrums (e.g. hitting, kicking, screaming) although he had no loss of verbalization skills noted instead of asking for things, he pointed or motioned and when not understood he screamed. Generally this child is very active, verbal, pleasant, sleeps through the night and had been potty trained for over 2 months. The evening of 10/6/04 he slept poorly and for the next 14 days he slept sporadically but for no longer than 23 hours at a time. Other family members noted the sudden change in his behavior; aunts, uncles, grandmother, in addition to his parents. It was thought to be just another phase in this 34 month olds development. Although he has asthma, he is only treated with albuterol when ill. He was healthy on 10/10/04 with no signs/symptoms of URI, but was so hyperactive he choked, coughed and progressed to having an asthma attack requiring 2 nebulizer Rx. The parents didn't know exactly what to think until their other 2 children's teachers called wondering if something was amiss at home since their response in school was unusual during that 2 weeks. At that time, the parents spoke with child's pediatrician and then today called about the vaccine. There are trace amounts of thimerosal in this vaccine. They wondered if it was vaccine related. Today, child is beginning to calm, has begun sleeping through the night approximately 1 week ago, has begun using the toilet again for approximately 1 week, speech is clearer, calmer, no tantrums for approximately 1 week. He had pink peeling skin on the palms of his hands and soles of his feet for approximately 3-4 days between 10/15/04 and 10/25/04; bad enough the parents told a friend.  (Child had hand/foot/mouth disease 5/04. This redness and peeling was not like that.). Child also began tripping and falling during the period of 10/10/04 until 10/25/04 which the parents attributed to new shoes, but this clumsiness persisted when he was barefoot. As of 10/31/04, his pink peeling skin has resolved, his excessive clumsiness has resolved. Overall, he seems to be improving to pre-vaccine status. Note: Some of his temper tantrums during this period lasted for up to 45 minutes and stopped only when the child was exhausted.) Looking back, the child stopped his language progression for 4 weeks after each of his 2 flu vaccines in 2003
Patient said he felt pressure in the arm during administration, about 5:30pm the arm started swelling, got red and warm to the touch. The next morning the swelling moved down to his elbow.
Patient tested positive for COVID 9/26/2021, chest pain, shortness of breath, cough and fever x1 week. Troponin elevated (58)
one full dose of the Moderna vaccine (0.5 ml)/received J&J's vaccine on 12MAR2021; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL OVERDOSE (one full dose of the Moderna vaccine (0.5 ml)/received J&J's vaccine on 12MAR2021) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012F21A) for COVID-19 vaccination.     Previously administered products included for COVID-19 vaccination: J&J on 12-Mar-2021. Past adverse reactions to the above products included No adverse event with J&J.    On 21-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 21-Oct-2021, the patient experienced ACCIDENTAL OVERDOSE (one full dose of the Moderna vaccine (0.5 ml)/received J&J's vaccine on 12MAR2021). On 21-Oct-2021, ACCIDENTAL OVERDOSE (one full dose of the Moderna vaccine (0.5 ml)/received J&J's vaccine on 12MAR2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were provided. No treatment information were provided.   Most recent FOLLOW-UP information incorporated above includes: On 25-Oct-2021: Follow up received contains Non-significant information